n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Bladder Cancer in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, G | 1 |
| Zhang, G | 1 |
| Chen, F | 1 |
| Cao, Y | 1 |
| Kalyanaraman, B | 1 |
| See, WA | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Bladder Cancer
| Article | Year |
|---|---|
iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology.
Topics: Amidines; BCG Vaccine; Benzylamines; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferat | 2014 |